CU20180159A7 - Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis - Google Patents

Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Info

Publication number
CU20180159A7
CU20180159A7 CU2018000159A CU20180159A CU20180159A7 CU 20180159 A7 CU20180159 A7 CU 20180159A7 CU 2018000159 A CU2018000159 A CU 2018000159A CU 20180159 A CU20180159 A CU 20180159A CU 20180159 A7 CU20180159 A7 CU 20180159A7
Authority
CU
Cuba
Prior art keywords
bordetella pertussis
synthetic
oligosaccharids
derivatives
vaccine against
Prior art date
Application number
CU2018000159A
Other languages
English (en)
Inventor
Guangwu Chen
Guo Lina
Fenández Castillo Sonsire
Guillermo Vérez Bencomo Vicente
Original Assignee
Chengdu Olisynn Biotechnology Co Ltd
Inst Finlay De Vacunas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Olisynn Biotechnology Co Ltd, Inst Finlay De Vacunas filed Critical Chengdu Olisynn Biotechnology Co Ltd
Priority to CU2018000159A priority Critical patent/CU20180159A7/es
Priority to CN201980000706.9A priority patent/CN111819184B/zh
Priority to PCT/CU2019/050001 priority patent/WO2020135898A1/es
Publication of CU20180159A7 publication Critical patent/CU20180159A7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)

Abstract

<p>La presente invención proporciona fragmentos de oligosacáridos sintéticos provenientes del pentasacárido terminal del lipooligosacárido de Bordetella pertussis, un método para obtener los fragmentos de oligosacáridos sintéticos y los conjugados a partir de los mismos. También proporciona las composiciones vacunales que contienen tales glicoconjugados y que inducen una respuesta inmune capaz de reducir la colonización nasofaríngea de Bordetella pertussis.</p>
CU2018000159A 2018-12-28 2018-12-28 Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis CU20180159A7 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CU2018000159A CU20180159A7 (es) 2018-12-28 2018-12-28 Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis
CN201980000706.9A CN111819184B (zh) 2018-12-28 2019-04-08 合成寡糖衍生物作为抗博德特百日咳杆菌疫苗
PCT/CU2019/050001 WO2020135898A1 (es) 2018-12-28 2019-04-08 Derivados de oligosacáridos sintéticos como vacuna contra bordetella pertussis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU2018000159A CU20180159A7 (es) 2018-12-28 2018-12-28 Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Publications (1)

Publication Number Publication Date
CU20180159A7 true CU20180159A7 (es) 2020-10-20

Family

ID=66793711

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2018000159A CU20180159A7 (es) 2018-12-28 2018-12-28 Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Country Status (3)

Country Link
CN (1) CN111819184B (es)
CU (1) CU20180159A7 (es)
WO (1) WO2020135898A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200201167A1 (ru) * 2000-06-02 2003-06-26 Пфайзер Продактс Инк. Производные гигромицина а для лечения бактериальных и протозойных инфекций
WO2012106251A2 (en) * 2011-01-31 2012-08-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Pertussis vaccine
PL404247A1 (pl) * 2013-06-07 2014-12-08 Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis
EP3242883A4 (en) * 2015-01-06 2018-10-17 ImmunoVaccine Technologies Inc. Lipid a mimics, methods of preparation, and uses thereof
WO2016168815A1 (en) * 2015-04-16 2016-10-20 Iventprise LLC Bordetella pertussis immunogenic vaccine compositions

Also Published As

Publication number Publication date
CN111819184A (zh) 2020-10-23
CN111819184B (zh) 2024-01-12
WO2020135898A1 (es) 2020-07-02

Similar Documents

Publication Publication Date Title
AR125320A2 (es) Compuesto cristalino, método de preparación y composición que lo comprende
CO2017011245A2 (es) Conjugados proteína-polisacárido de estreptococo grupo b, métodos para producir conjugados, composiciones inmunógenas que comprenden conjugados y sus usos
WO2015168379A3 (en) Combination vaccine devices and methods of killing cancer cells
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
EP3616716A3 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
BR112021012037A2 (pt) Molécula anti-pd-1/il-7 bifuncional
CO2020001927A2 (es) Método de producción de composiciones farmacéuticas que comprende el virus chikungunya inmunogénico chikv-delta5nsp3
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
BR112019003577A2 (pt) métodos de tratamento da semente e produtos resultantes
UY33297A (es) Composiciones farmaceuticas que comprenden un polipéptido que comprende al menos un motivo cxxc y antígenos heterólogos y usos de las mismas
BR112015018270A2 (pt) composições que compreendem 15-ohepa e métodos de uso das mesmas
EA201990010A1 (ru) Вакцина против вируса инфекционного бронхита
BR112019003992A2 (pt) vacina contra neisseria meningitidis
BR112017004197A2 (pt) composições de vacina contra doenças do vírus da dengue
EA201691915A1 (ru) ИММУНОЛОГИЧЕСКИЕ КОМПОЗИЦИИ, ВКЛЮЧАЮЩИЕ ОСЛАБЛЕННЫЕ Histophilus somni
AR105010A1 (es) Composiciones inmunógenas
BR112017015288A2 (pt) vacina contra febre aftosa
CO2023006684A2 (es) Anticuerpos contra sars-cov-2 y usos de los mismos
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
CY1125699T1 (el) Συνθεσεις mycoplasma bovis
BR112018074910A2 (pt) composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito
PL404247A1 (pl) Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis
BR112017028224A2 (pt) composição, e, método para proteger um leitão contra uma doença associada a pestivírus.
MX2016009888A (es) Procedimiento para el tratamiento o la prevencion de condiciones inmunes relacionadas con infecciones utilizando una composicion que comprende igm.
WO2019017499A3 (en) PHARMACEUTICAL COMPOSITION